Ariz. Admin. Code § R9-6-3101 - Vancomycin-Resistant or Vancomycin-Intermediate Staphylococcus aureus

Case control measures:

1. A diagnosing health care provider or an administrator of a health care institution, either personally or through a representative, shall isolate and implement contact precautions for a case or suspect case of vancomycin-resistant or vancomycin-intermediate Staphylococcus aureus.

2. A diagnosing health care provider or an administrator of a health care institution transferring a known case with active infection or a known carrier of vancomycin-resistant or vancomycin-intermediate Staphylococcus aureus to another health care provider or health care institution shall, either personally or through a representative, comply with R9-6-305.

3. A local health agency, in consultation with the Department, shall:

a. Upon receiving a report of a case or suspect case of vancomycin-resistant or vancomycin-intermediate Staphylococcus aureus, notify the Department within one working day after receiving the report and provide to the Department the information contained in the report;

b. Ensure that a case or suspect case of vancomycin-resistant or vancomycin-intermediate Staphylococcus aureus is isolated as necessary to prevent transmission;

c. Conduct an epidemiologic investigation of each reported case or suspect case of vancomycin-resistant or vancomycin-inter-mediate Staphylococcus aureus;

d. For each case of vancomycin-resistant or vancomycin-intermediate Staphylococcus aureus, submit to the Department, as specified in Table 2.4, the information required under R9-6-206(D); and

e. In consultation with the Department, ensure that an isolate or a specimen, as available, from each case of vancomycin-resistant or vancomycin-intermediate Staphylococcus aureus is submitted to the Arizona State Laboratory.

Notes

Ariz. Admin. Code § R9-6-3101

New Section Renumbered from R9-6-391 by final rulemaking at 31 A.A.R. 1319, effective 6/2/2025.